What does the evidence say about Calcium Vitamin D Fracture Randomized Trial?

The current Migaku evidence database contains 2 reusable source documents for Calcium Vitamin D Fracture Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - Statistical analysis was performed using appropriate parametric and non-parametric tests, with P Results Both supplementation regimens significantly improved serum Vitamin D levels; however, the weekly regimen achieved higher levels at 12 weeks (32.8 ± 7.4 ng/mL vs. [Selvaraj NV (2026); evidence level 2] - Serum calcium levels increased and PTH levels decreased significantly, with greater changes observed in the weekly supplementation group. [Selvaraj NV (2026); evidence level 2] - Conclusion Weekly high-dose Vitamin D supplementation resulted in superior biochemical correction and faster fracture healing compared to daily low-dose supplementation in Vitamin D-deficient patients with long-bone fractures. [Selvaraj NV (2026); evidence level 2] - Introduction Vitamin D plays a critical role in bone metabolism and mineralization, and deficiency is highly prevalent among patients presenting with long-bone fractures. [Selvaraj NV (2026); evidence level 2] - Moreover, growing evidence suggesting an increased fall risk associated with high-dose bolus administration has necessitated a re-evaluation of safety assumptions. [Kong SH (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.